RadNet, Inc. Proceeds from Common Stock Issued
RadNet, Inc. (RDNT) reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-03-02
- RadNet, Inc. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $0.00.
- RadNet, Inc. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00.
- RadNet, Inc. proceeds from issuance of common stock for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- RadNet, Inc. proceeds from issuance of common stock for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- RadNet, Inc. proceeds from issuance of common stock for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- RadNet, Inc. proceeds from issuance of common stock for fiscal 2024 was $218.38M, a 11.16% decline from fiscal 2023.
- RadNet, Inc. proceeds from issuance of common stock for fiscal 2023 was $245.83M.
- RadNet, Inc. proceeds from issuance of common stock for fiscal 2022 was $0.00.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | $0.00 derived: sum of 3 quarters · filed 2026-03-02 | $0.00 10-K · filed 2026-03-02 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2026-03-02 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-03-02 | $0.00 derived: sum of 4 quarters · filed 2026-03-02 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | $0.00 derived: sum of 3 quarters · filed 2026-03-02 | $2.00K derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | $2.00K derived: sum of 3 quarters · filed 2026-03-02 | $218.38M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.00K derived: sum of 2 quarters · filed 2025-11-10 | $218.38M 10-Q · filed 2025-11-10 | $218.39M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $218.38M 10-Q · filed 2025-08-11 | $218.39M derived: sum of 3 quarters · filed 2026-03-02 | $218.01M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-03-31 | $218.38M 10-Q · filed 2025-05-12 | $218.38M 10-Q · filed 2024-05-10 | $218.38M derived: sum of 2 quarters · filed 2026-03-02 | $218.01M derived: sum of 3 quarters · filed 2026-03-02 | $464.21M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$370.00K derived: sum of 2 quarters · filed 2026-03-02 | $245.83M derived: sum of 3 quarters · filed 2026-03-02 | $245.83M 10-K · filed 2026-03-02 | |
| 2023-09-30 | -$371.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $245.83M derived: sum of 2 quarters · filed 2024-11-12 | $245.83M 10-Q · filed 2024-11-12 | $245.83M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $246.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $246.20M 10-Q · filed 2024-08-09 | $246.20M derived: sum of 3 quarters · filed 2025-03-03 | $246.20M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | ||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |